A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers

References

• Abbas A, Gupta S. (2008). The role of histone deacetylases in prostate cancer. Epigenetics 3:300–9.
   PubMed Web of Science ®Google Scholar
• Ahn J-M, Cho J-Y. (2013). Current serum lung cancer biomarkers. J Mol Biomark Diagn S4:001.
   Google Scholar
• Almeida M, Costa VL, Costa NR, et al. (2014). Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential. J Cell Mol Med 18:2287–97.
   PubMed Web of Science ®Google Scholar
• Alnaes G, Ronneberg JA, Kristensen VN, Tost J. (2015). Heterogeneous DNA methylation patterns in the GSTP1 promoter lead to discordant results between assay technologies and impede its implementation as epigenetic biomarkers in breast cancer. Genes (Basel) 6:878–900.
   PubMed Web of Science ®Google Scholar
• Alyea RA, Moore NP, LeBaron MJ, et al. (2012). Is the current product safety assessment paradigm protective for epigenetic mechanisms? J Pharmacol Toxicol Methods 66:207–14.
   PubMed Web of Science ®Google Scholar
• Ashktorab H, Brim H. (2014). DNA methylation and colorectal cancer. Curr Colorectal Cancer Rep 10:425–30.
   PubMedGoogle Scholar
• Auclair G, Weber M. (2012). Mechanisms of DNA methylation and demethylation in mammals. Biochimie 94:2202–11.
   PubMed Web of Science ®Google Scholar
• Avraham R, Yarden Y. (2012). Regulation of signalling by microRNAs. Biochem Soc Trans 40:26–30.
   PubMed Web of Science ®Google Scholar
• Bastos EP, Brentani H, Pasini FS, et al. (2014). MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients ≤35 years. PLoS One 9:e101656.
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Meissner A, Lander ES. (2007). The mammalian epigenome. Cell 128:669–81.
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Stamatoyannopoulos JA, Costello JF, et al. (2010). The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol 28:1045–8.
   PubMed Web of Science ®Google Scholar
• Bhatt AN, Mathur R, Farooque A, et al. (2010). Cancer biomarkers – current perspectives. Indian J Med Res 132:129–49.
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95.
   PubMed Web of Science ®Google Scholar
• Bolton EM, Tuzova AV, Walsh AL, et al. (2014). Noncoding RNAs in prostate cancer: the long and the short of it. Clin Cancer Res 20:35–43.
   PubMed Web of Science ®Google Scholar
• Botezatu A, Bleotu C, Nastase A, et al. (2015). Epigenetic silencing of GNMT gene in pancreatic adenocarcinoma. Cancer Genomics Proteomics 12:21–30.
   PubMed Web of Science ®Google Scholar
• Byler S, Goldgar S, Heerboth S, et al. (2014). Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res 34:1071–7.
   PubMed Web of Science ®Google Scholar
• Cai H, Yuan Y, Hao YF, et al. (2013). Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol 30:452.
   PubMed Web of Science ®Google Scholar
• Cancer Statistics. The National Cancer Institute, National Institutes of Health. Available from: http://www.cancer.gov/about-cancer/what-is-cancer/statistics [last accessed 10 Feb 2015].
   Google Scholar
• Carpelan-Holmström M, Nordling S, Pukkala E, et al. (2005). Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54:385–7.
   PubMed Web of Science ®Google Scholar
• Chang S, Wang RH, Akagi K, et al. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). (2011). Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med 17:1275–82.
   PubMed Web of Science ®Google Scholar
• Chen WD, Han ZJ, Skoletsky J, et al. (2005). Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 97:1124–32.
   PubMed Web of Science ®Google Scholar
• Chen WY, Zhao XJ, Yu ZF, et al. (2015). The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Int J Clin Exp Pathol 8:7092–101.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li J, Yu X, et al. (2013). Eur J Hum Genet 21:929–35.
   PubMed Web of Science ®Google Scholar
• Chervona Y, Costa M. (2012). Histone modifications and cancer: biomarkers of prognosis? Am J Cancer Res 2:589–97.
   PubMed Web of Science ®Google Scholar
• Cheung KF, Lam CN, Wu K, et al. (2012). Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer 118:947–59.
   PubMed Web of Science ®Google Scholar
• Chiam K, Ricciardelli C, Bianco-Miotto T. (2014). Epigenetic biomarkers in prostate cancer: current and future uses. Cancer Lett 342:248–56.
   PubMed Web of Science ®Google Scholar
• Chiba T, Marusawa H, Ushijima T. (2012). Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 143:550–63.
   PubMed Web of Science ®Google Scholar
• de Groot JS, Pan X, Meeldijk J, et al. (2014). Validation of DNA promoter hypermethylation biomarkers in breast cancer – a short report. Cell Oncol (Dordr) 37:297–303.
   PubMed Web of Science ®Google Scholar
• deVos T, Tetzner R, Model F, et al. (2009). Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 55:1337–46.
   PubMed Web of Science ®Google Scholar
• Dhaliwal A, Vlachostergios PJ, Oikonomou KG, Moshenyat Y. (2015). Fecal DNA testing for colorectal cancer screening: molecular targets and perspectives. World J Gastrointest Oncol 7:178–83.
   PubMed Web of Science ®Google Scholar
• Dietrich D, Kneip C, Raji O, et al. (2012). Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int J Oncol 40:825–32.
   PubMed Web of Science ®Google Scholar
• di Mario F, Cavallaro LG. (2008). Non-invasive tests in gastric diseases. Dig Liver Dis 40:523–30.
   PubMedGoogle Scholar
• Dobosy JR, Roberts JL, Fu VX, Jarrard DF. (2007). The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J Urol 177:822–31.
   PubMed Web of Science ®Google Scholar
• Duffy MJ. (2006). Serum tumor markers in breast cancer: are they of clinical value? Clin Chem 52:345–51.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, Sturgeon CM, Sölétormos G, et al. (2015). Validation of new cancer biomarkers: a position statement from the European group on tumor markers. Clin Chem 61:809–20.
   PubMed Web of Science ®Google Scholar
• Dupont C, Armant DR, Brenner CA. (2009). Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med 27:351–7.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. (2006). Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 6:259–69.
   PubMed Web of Science ®Google Scholar
• Esteban-Jurado C, Garre P, Vila M, et al. (2014). New genes emerging for colorectal cancer predisposition. World J Gastroenterol 20:1961–71.
   PubMed Web of Science ®Google Scholar
• Esteller M, Silva JM, Dominguez G, et al. (2000). Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564–9.
   PubMed Web of Science ®Google Scholar
• Fackler MJ, Lopez Bujanda Z, Umbricht C, et al. (2014). Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res 74:2160–70.
   PubMed Web of Science ®Google Scholar
• Fanali C, Lucchetti D, Farina M, et al. (2014). Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives. World J Gastroenterol 20:923–42.
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Vogelstein B. (1983). Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89–92.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86.
   PubMed Web of Science ®Google Scholar
• Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, et al. (2015). Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepat Med 7:1–10.
   PubMedGoogle Scholar
• Ficz G, Gribben JG. (2014). Loss of 5-hydroxymethylcytosine in cancer: Cause or consequence? Genomics 104:352–7.
   PubMed Web of Science ®Google Scholar
• Frommer M, McDonald LE, Millar DS, et al. (1992). A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827–31.
   PubMed Web of Science ®Google Scholar
• Fu Y, Wei X, Tang C, et al. (2013). Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Oncol Lett 6:1811–15.
   PubMed Web of Science ®Google Scholar
• Fukushige S, Horii A. (2014). Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers. Cancer Lett 342:231–7.
   PubMed Web of Science ®Google Scholar
• Füzéry AK, Levin J, Chan MM, Chan DW. (2013). Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics 10:13. doi: 10.1186/1559-0275-10-13.
   PubMed Web of Science ®Google Scholar
• García-Giménez JL, Sanchis-Gomar F, Lippi G, et al. (2012). Epigenetic biomarkers: A new perspective in laboratory diagnostics. Clin Chim Acta 413:1576–82.
   PubMed Web of Science ®Google Scholar
• Giovanella L, Ceriani L, Bandera M, Garancini S. (2001). Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase. Int J Biol Markers 16:50–5.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Pons M, Cruz-Correa M. (2015). Colorectal cancer biomarkers: where are we now? Biomed Res Int 2015:149014.
   PubMed Web of Science ®Google Scholar
• Grunau C, Clark SJ, Rosenthal A. (2001). Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Research 29:E65–5.
   PubMedGoogle Scholar
• Gu J, Wang D, Huang Y, et al. (2014). Diagnostic value of combining CA 19-9 and K-ras gene mutation in pancreatic carcinoma: a meta-analysis. Int J Clin Exp Med 7:3225–34.
   PubMed Web of Science ®Google Scholar
• Guan P, Yin Z, Li X, et al. (2012). Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res 31:54.. doi: 10.1186/1756-9966-31-54.
   PubMed Web of Science ®Google Scholar
• Guo J, Friedman SL. (2013). The expression patterns and clinical significance of microRNAs in liver diseases and hepatocellular carcinoma. Curr Pharm Des 19:1262–72.
   PubMed Web of Science ®Google Scholar
• Haag T, Herkt CE, Walesch SK, et al. (2014). The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms. Genes Cancer 5:365–74.
   PubMedGoogle Scholar
• Han Y, Garcia BA. (2013). Combining genomic and proteomic approaches for epigenetics research. Epigenomics 5:439–52.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. (2011). Hallmarks of cancer: the next generation. Cell 144:646–74.
   PubMed Web of Science ®Google Scholar
• Herceg Z, Hainaut P. (2007). Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol Oncol 1:26–41.
   PubMed Web of Science ®Google Scholar
• Herceg Z, Paliwal A. (2011). Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat Res 727:55–61.
   PubMed Web of Science ®Google Scholar
• Hernández HG, Tse MY, Pang SC, et al. (2013). Optimizing methodologies for PCR-based DNA methylation analysis. Biotechniques 55:181–97.
   PubMed Web of Science ®Google Scholar
• Hirst M, Marra MA. (2009). Epigenetics and human disease. Int J Biochem Cell Biol 41:136–46.
   PubMed Web of Science ®Google Scholar
• Hoffman A, Teubner D, Kiesslich R. (2014). Competition in Colon Cancer Screening? What Is the Role of Colonoscopy? Viszeralmedizin 30:18–25.
   PubMedGoogle Scholar
• Hoshida Y, Toffanin S, Lachenmayer A, et al. (2010). Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 30:35–51.
   PubMed Web of Science ®Google Scholar
• Hu L, Chen G, Yu H, Qiu X. (2010). Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma. Hepatol Int 4:423–32.
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang D, Ni S, et al. (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127:118–26.
   PubMed Web of Science ®Google Scholar
• Huang Z, Liu F. (2014). Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis. Tumour Biol 35:7459–65.
   PubMed Web of Science ®Google Scholar
• Huang J, Zeng Y. (2014). Current clinical uses of the biomarkers for hepatocellular carcinoma. Drug Discov Ther 8:98–9.
   PubMedGoogle Scholar
• Illingworth RS, Bird AP. (2009). CpG islands – ‘a rough guide’. FEBS Lett 583:1713–20.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. (2014). Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370:1287–97.
   PubMed Web of Science ®Google Scholar
• Iorio MV, Ferracin M, Liu CG, et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–70.
   PubMed Web of Science ®Google Scholar
• Isin M, Dalay N. (2015). LncRNAs and neoplasia. Clin Chim Acta 444:280–8.
   PubMed Web of Science ®Google Scholar
• Issa JP, Ahuja N, Toyota M, et al. (2001). Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61:3573–7.
   PubMed Web of Science ®Google Scholar
• Jain S, Xie L, Boldbaatar B, et al. (2014). Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis. Hepatol Res 45:1110–23.
   PubMed Web of Science ®Google Scholar
• Jasperson KW, Tuohy TM, Neklason DW, Burt RW. (2010). Hereditary and familial colon cancer. Gastroenterology 138:2044–58.
   PubMed Web of Science ®Google Scholar
• Jerónimo C, Henrique R, Hoque MO, et al. (2004). A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 10:8472–8.
   PubMed Web of Science ®Google Scholar
• Jones S, Jones S, Zhang X, et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801–6.
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. (2007). The epigenomics of cancer. Cell 128:683–92.
   PubMed Web of Science ®Google Scholar
• Kalniņa Z, Meistere I, Kikuste I, et al. (2015). Emerging blood-based biomarkers for detection of gastric cancer. World J Gastroenterol 21:11636–53.
   PubMed Web of Science ®Google Scholar
• Kanaan Z, Roberts H, Eichenberger MR, et al. (2013). A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Ann Surg 258:400–8.
   PubMed Web of Science ®Google Scholar
• Kaneda A, Yagi K. (2011). Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes. Cancer Sci 102:18–24.
   PubMed Web of Science ®Google Scholar
• Kanwal R, Gupta S. (2010). Epigenetics and cancer. J Appl Physiol 109:598–605.
   PubMed Web of Science ®Google Scholar
• Kelly BD, Miller N, Healy NA, et al. (2013). A review of expression profiling of circulating microRNAs in men with prostate cancer. BJU Int 111:17–21.
   PubMed Web of Science ®Google Scholar
• Kim MS, Lee J, Oh T, et al. (2012). Genome-wide identification of OTP gene as a novel methylation marker of breast cancer. Oncol Rep 27:1681–8.
   PubMed Web of Science ®Google Scholar
• Kloten V, Becker B, Winner K, et al. (2013). Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening. Breast Cancer Res 15:R4.
   PubMed Web of Science ®Google Scholar
• Kneip C, Schmidt B, Seegebarth A, et al. (2011). SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol 6:1632–8.
   PubMed Web of Science ®Google Scholar
• Kouzarides T. (2007). Chromatin modifications and their function. Cell 128:693–705.
   PubMed Web of Science ®Google Scholar
• Kundaje A, Meuleman W, Ernst J. Roadmap Epigenomics Consortium, et al. (2015). Integrative analysis of 111 reference human epigenomes. Nature 518:317–30.
   PubMed Web of Science ®Google Scholar
• Kunej T, Godnic I, Ferdin J, et al. (2011). Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res 717:77–84.
   PubMed Web of Science ®Google Scholar
• Laird PW. (2003). The power and the promise of DNA methylation markers. Nat Rev Cancer 3:253–66.
   PubMed Web of Science ®Google Scholar
• Lambert MP, Herceg Z. (2008). Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007. Mol Oncol 2:33–40.
   PubMed Web of Science ®Google Scholar
• Langer CJ, Besse B, Gualberto A, et al. (2010). The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol 28:5311–20.
   PubMed Web of Science ®Google Scholar
• Langevin SM, Kratzke RA, Kelsey KT. (2015). Epigenetics of lung cancer. Trans Res 165:74–90.
   Web of Science ®Google Scholar
• Laurent LC, Abdel-Mageed AB, Adelson PD, et al. (2015). Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium. J Extracell Vesicles 4:26533.
   PubMed Web of Science ®Google Scholar
• Leontiou CA, Hadjidaniel MD, Mina P, et al. (2015). Bisulfite conversion of DNA: performance comparison of different kits and methylation quantitation of epigenetic biomarkers that have the potential to be used in non-invasive prenatal testing. PLoS One 10:e0135058.
   PubMed Web of Science ®Google Scholar
• Lewandowska J, Bartoszek A. (2011). DNA methylation in cancer development, diagnosis and therapy-multiple opportunities for genotoxic agents to act as methylome disruptors or remediators. Mutagenesis 26:475–87.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20.
   PubMed Web of Science ®Google Scholar
• Li H, Zheng T, Chen B, et al. (2014a). Similar blood-borne DNA methylation alterations in cancer and inflammatory diseases determined by subpopulation shifts in peripheral leukocytes. Br J Cancer 111:525–31.
   PubMed Web of Science ®Google Scholar
• Li J, Jin H, Wang X. (2014b). Epigenetic biomarkers: potential applications in gastrointestinal cancers. ISRN Gastroenterol 2014:464015.
   PubMedGoogle Scholar
• Li C, Li JF, Cai Q, et al. (2013a). MiRNA-199a-3p: a potential circulating diagnostic biomarker for early gastric cancer. J Surg Oncol 108:89–92.
   PubMed Web of Science ®Google Scholar
• Li C, Li JF, Cai Q, et al. (2013b). miRNA- 199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Ann Surg Oncol 20:S397–405.
   PubMed Web of Science ®Google Scholar
• Lian ZQ, Wang Q, Li WP, et al. (2012). Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels. Int J Oncol 41:629–38.
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang C, Hu Z, et al. (2011). A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 47:784–91.
   PubMed Web of Science ®Google Scholar
• Liu C, Kelnar K, Vlassov AV, et al. (2012a). Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res 72:3393–404.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhu L, Liu B, et al. (2012b). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316:196–203.
   PubMed Web of Science ®Google Scholar
• Liu HS, Xiao HS. (2014). MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol 20:12007–17.
   PubMed Web of Science ®Google Scholar
• Liu GH, Zhou ZG, Chen R, et al. (2013). Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer. Tumour Biol 34:2175–81.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J, (2003). Hepatocellular carcinoma. Lancet 362:1907–17.
   PubMed Web of Science ®Google Scholar
• Lofton-Day C, Model F, Devos T, et al. (2008). DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54:414–23.
   PubMed Web of Science ®Google Scholar
• Lopez JP, Diallo A, Cruceanu, et al. (2015). Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing. BMC Med Genomics 8:35.
   PubMed Web of Science ®Google Scholar
• Mahon KL, Qu W, Devaney J, et al. PRIMe consortium. (2014). Methylated glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer. Br J Cancer 111:1802–9.
   PubMed Web of Science ®Google Scholar
• Malumbres M. (2013). miRNAs and cancer: an epigenetics view. Mol Aspects Med 34:863–74.
   PubMed Web of Science ®Google Scholar
• Mann DA. (2014). Epigenetics in liver disease. Hepatology 60:1418–25.
   PubMed Web of Science ®Google Scholar
• Maroof H, Salajegheh A, Smith RA, Lam AK. (2014). MicroRNA-34 family, mechanisms of action in cancer: a review. Curr Cancer Drug Targets 14:737–51.
   PubMed Web of Science ®Google Scholar
• Meng H, Cao Y, Qin J, et al. (2015). DNA methylation, its mediators and genome integrity. Int J Biol Sci 11:604–17.
   PubMed Web of Science ®Google Scholar
• Miller JA. (1970). Carcinogenesis by chemicals: an overview – G. H. A. Clowes memorial lecture. Cancer Res 30:559–76.
   PubMed Web of Science ®Google Scholar
• Millot GA, Carvalho MA, Caputo SM, et al. ENIGMA Consortium Functional Assay Working Group. (2012). A guide for functional analysis of BRCA1 variants of uncertain significance. Hum Mutat 33:1526–37.
   PubMed Web of Science ®Google Scholar
• Mitchell SM, Ross JP, Drew HR, et al. (2014). A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer 14:54.
   PubMed Web of Science ®Google Scholar
• Montani F, Marzi MJ, Dezi F, et al. (2015). miR-Test: a blood test for lung cancer early detection. J Natl Cancer Inst 107:djv063.
   PubMedGoogle Scholar
• Morikawa T, Kato J, Yamaji Y, et al. (2005). A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129:422–8.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Screening Tests. (2015). Available from: http://www.cancer.gov/about-cancer/screening/screening-tests [last accessed 8 Jan 2016].
   Google Scholar
• National Cancer Institute. Tumor Markers. (2015). Available from: http://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet [last accessed 8 Jan 2016].
   Google Scholar
• Ned RM, Melillo S, Marrone M. (2011). Fecal DNA testing for colorectal cancer screening: the ColoSure™ test. PLoS Curr 3:RRN12202011.
   PubMedGoogle Scholar
• Nestor CE, Ottaviano R, Reddington J, et al. (2012). Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res 22:467–77.
   PubMed Web of Science ®Google Scholar
• Neureiter D, Jäger T, Ocker M, Kiesslich T. (2014). Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects. World J Gastroenterol 20:7830–48.
   PubMed Web of Science ®Google Scholar
• Ng EK, Li R, Shin VY, et al. (2013). Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS One 8:e53141.
   PubMed Web of Science ®Google Scholar
• Ng EKO, Chong WWS, Jin H, et al. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58:1375–81.
   PubMed Web of Science ®Google Scholar
• Ng JM, Yu J. (2015). Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci 16:2472–96.
   PubMed Web of Science ®Google Scholar
• Nguyen HC, Xie W, Yang M, et al. (2013). Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. Prostate 73:346–54.
   PubMed Web of Science ®Google Scholar
• Nielsen M, Hes FJ, Nagengast FM, et al. (2007). Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 71:427–33.
   PubMed Web of Science ®Google Scholar
• Nishida N, Goel A. (2011). Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics 12:130–7.
   PubMed Web of Science ®Google Scholar
• Nishida N, Kudo M, Nagasaka T, et al. (2012). Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma. Hepatology 56:994–1003.
   PubMed Web of Science ®Google Scholar
• Novak K. (2004). Epigenetics changes in cancer cells: highlights of the American Association for Cancer Research Special Conference on Chromatin, Chromosomes, and Cancer Epigenetics. MedGenMed 2004;6:17.
   Google Scholar
• Oh T, Kim N, Moon Y, et al. (2013). Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. J Mol Diagn 15:498–507.
   PubMed Web of Science ®Google Scholar
• Oishi N, Yamashita T, Kaneko S. (2014). Molecular biology of liver cancer stem cells. Liver Cancer 3:71–84.
   PubMed Web of Science ®Google Scholar
• Omura N, Li CP, Li A, et al. (2008). Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther 7:1146–56.
   PubMed Web of Science ®Google Scholar
• Osborn NK, Ahlquist DA. (2005). Stool screening for colorectal cancer: molecular approaches. Gastroenterology 128:192–206.
   PubMed Web of Science ®Google Scholar
• Paska AV, Hudler P. (2015). Aberrant methylation patterns in cancer: a clinical view. Biochem Med (Zagreb) 25:161–76.
   PubMed Web of Science ®Google Scholar
• Pedersen SK, Baker RT, McEvoy A, et al. (2015). A two-gene blood test for methylated DNA sensitive for colorectal cancer. PLoS One 10:e0125041.
   PubMed Web of Science ®Google Scholar
• Perkins GL, Slater ED, Sanders GK, Prichard JG. (2003). Serum tumor markers. Am Fam Physician 68:1075–82.
   PubMed Web of Science ®Google Scholar
• Peserico A, Simone C. (2011). Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol 2011:371832.
   PubMedGoogle Scholar
• Piazuelo MB, Correa P. (2013). Gastric cáncer: overview. Colomb Med (CA) 44:192–201.
   PubMed Web of Science ®Google Scholar
• Pogribny IP. (2014). Investigating the role of epigenetics for carcinogen identification. Epigenetics and selected biomarkers of organ toxicity SAB, November 7, 2014. Available from: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/toxicologicalresearch/ucm419140.pdf [last accessed 24 Sep 2015].
   Google Scholar
• Pogribny IP, Muskhelishvili L, Tryndyak VP, Beland FA. (2011). The role of epigenetic events in genotoxic hepatocarcinogenesis induced by 2-acetylaminofluorene. Mutat Res 722:106–13.
   PubMed Web of Science ®Google Scholar
• Pogribny IP, Rusyn I. (2013). Environmental toxicants, epigenetics, and cancer. Adv Exp Med Biol 754:215–32.
   PubMed Web of Science ®Google Scholar
• Pogribny IP, Rusyn I. (2014). Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett 342:223–30.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Barry MJ, Denberg TD, et al. Clinical Guidelines Committee of the American College of Physicians. (2013). Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 158:761–9.
   PubMed Web of Science ®Google Scholar
• Rasoulpour RJ, LeBaron MJ, Ellis-Hutchings RG, et al. (2011). Epigenetic screening in product safety assessment: are we there yet? Toxicol Mech Methods 21:298–311.
   PubMed Web of Science ®Google Scholar
• Redzic JS, Balaj L, van der Vos KE, Breakefield XO. (2014). Extracellular RNA mediates and marks cancer progression. Semin Cancer Biol 28:14–23.
   PubMed Web of Science ®Google Scholar
• Ren A, Dong Y, Tsoi H, Yu J. (2015). Detection of miRNA as non-invasive biomarkers of colorectal cancer. Int J Mol Sci 16:2810–23.
   PubMed Web of Science ®Google Scholar
• Sadakierska-Chudy A, Filip M. (2015). A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs. Neurotox Res 27:172–97.
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Yoon SK, Lencioni R. (2010). The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 15:14–22.
   PubMed Web of Science ®Google Scholar
• Salvi S, Gurioli G, Martignano F, et al. (2015). Urine cell-free DNA integrity analysis for early detection of prostate cancer patients. Dis Markers 2015:574120. doi: 10.1155/2015/574120.
   Web of Science ®Google Scholar
• Sapari NS, Loh M, Vaithilingam A, Soong R. (2012). Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One 7:e36275.
   PubMed Web of Science ®Google Scholar
• Scaggiante B, Kazemi M, Pozzato G, et al. (2014). Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. World J Gastroenterol 20:1268–88.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Beyer J, Dietrich D, et al. (2015). Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients. PLoS One 10:e0118195.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Liebenberg V, Dietrich D, et al. (2010). SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 10:600.
   PubMed Web of Science ®Google Scholar
• Short E, Thomas LE, Hurley J, et al. (2015). Inherited predisposition to colorectal cancer: towards a more complete picture. J Med Genet 52:791–6.
   PubMed Web of Science ®Google Scholar
• Song BP, Jain S, Lin SY, et al. (2012). Detection of hypermethylated vimentin in urine of patients with colorectal cancer. J Mol Diagn 14:112–19.
   PubMed Web of Science ®Google Scholar
• Sørensen CG, Karlsson WK, Pommergaard HC, et al. (2015). The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence – a systematic review. Int J Surg 25:134–44.
   PubMed Web of Science ®Google Scholar
• Stefansson OA, Moran S, Gomez A, et al. (2015). A DNA methylation-based definition of biologically distinct breast cancer subtypes. Mol Oncol 9:555–68.
   PubMed Web of Science ®Google Scholar
• Stephens PJ, Tarpey PS, Davies H, et al. (2012). The landscape of cancer genes and mutational processes in breast cancer. Nature 486:400–4.
   PubMed Web of Science ®Google Scholar
• Stewart GD, Van Neste L, Delvenne P, et al. (2013). Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study. J Urol 189:1110–16.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Tsujiura M, Ichikawa D, Komatsu S, et al. (2010). Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102:1174–9.
   PubMed Web of Science ®Google Scholar
• van Rooij E. (2011). The art of microRNA research. Circ Res 108:219–34.
   PubMed Web of Science ®Google Scholar
• Vatandoost N, Ghanbari J, Mojaver M, et al. (2015). Early detection of colorectal cancer: from conventional methods to novel biomarkers. J Cancer Res Clin Oncol 142:341–51.
   PubMed Web of Science ®Google Scholar
• Verma M, Rogers S, Divi RL, et al. (2014). Epigenetic research in cancer epidemiology: trends, opportunities, and challenges. Cancer Epidemiol Biomarkers Prev 23:223–33.
   PubMed Web of Science ®Google Scholar
• Walser T, Cui X, Yanagawa J, et al. (2008). Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc 5:811–15.
   PubMedGoogle Scholar
• Warton K, Samimi G. (2015). Methylation of cell-free circulating DNA in the diagnosis of cancer. Front Mol Biosci 2:13. doi: 10.3389/fmolb.2015.00013.
   PubMed Web of Science ®Google Scholar
• Weirich CS, Erzberger JP, Barral Y. (2008). The septin family of GTPases: Architecture and dynamics. Nat. Rev. Mol. Cell Biol 9:478–89.
   PubMed Web of Science ®Google Scholar
• Westcott JM, Prechtl AM, Maine EA, et al. (2015). An epigenetically distinct breast cancer cell subpopulation promotes collective invasion. J Clin Invest 125:1927–43.
   PubMed Web of Science ®Google Scholar
• Wolf AM, Wender RC, Etzioni RB, et al. (2010). American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 60:70–98.
   PubMed Web of Science ®Google Scholar
• Wu J, Li G, Yao Y, et al. (2015). MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. Biomarkers 20:58–63.
   PubMed Web of Science ®Google Scholar
• Xu J, Wu C, Che X, et al. (2011). Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50:136–42.
   PubMed Web of Science ®Google Scholar
• Yang H, Liu Y, Bai F, et al. (2013). Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 32:663–9.
   PubMed Web of Science ®Google Scholar
• Yang YA, Yu J. (2013). EZH2, an epigenetic driver of prostate cancer. Protein Cell 4:331–41.
   PubMed Web of Science ®Google Scholar
• Yasmin R, Siraj S, Hassan A, et al. (2015). Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies. Mediators Inflamm 2015:201703.
   PubMed Web of Science ®Google Scholar
• Yi JM, Guzzetta AA, Bailey VJ, et al. (2013). Novel methylation biomarker panel for the early detection of pancreatic cancer. Clin Cancer Res 19:6544–55.
   PubMed Web of Science ®Google Scholar
• Zeng XL, Zhang SY, Zheng JF, et al. (2013). Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer. Chin Med J (Engl) 126:4510–16.
   PubMed Web of Science ®Google Scholar
• Zhang L, Song X, Wang X, et al. (2015a). Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer. Breast Cancer Res Treat 152:199–208.
   PubMed Web of Science ®Google Scholar
• Zhang X, Song YF, Lu HN, et al. (2015b). Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas. World J Gastroenterol 21:2629–37.
   PubMed Web of Science ®Google Scholar
• Zhang G, Pradhan S. (2014). Mammalian epigenetic mechanisms. IUBMB Life 66:240–56.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang R, Song H, et al. (2011). Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett 303:21–8.
   PubMed Web of Science ®Google Scholar
• Zhou YF, Xu W, Wang X, et al. (2014). Negative methylation status of vimentin predicts improved prognosis in pancreatic carcinoma. World J Gastroenterol 20:13172–7.
   PubMed Web of Science ®Google Scholar